Bloomberg
Moderna CEO Hopes to Get Vaccine Approval in Next Few Weeks
Nov.30 -- Moderna Chief Executive Officer Stephane Bancel says the company is on track to deliver up to 20 million vaccine doses in the U.S. before the end of the year and warns teenagers against getting vaccinated because there's no...
Curated Video
FDA Advisory Committee To Meet Thursday
Pentagon officials will give an update on the nation's vaccine distribution plans.
Curated Video
FDA Funds Rapid Tests, Approves At-Home COVID Tests
Home tests will be available in a few weeks.
Bloomberg
Novavax Expects Vaccinations to Begin in U.K. in April: CEO
Jan.29 -- Novavax Chief Executive Officer Stan Erck discusses efficacy data from trials of the company’s Covid-19 vaccine, the time frame for approval and delivery of the vaccine, and work on a reformulated version for virus variants. He...
Curated Video
FDA Authorizes Second Pfizer, Moderna Booster For Americans 50 And Up
U.S. regulators authorized a fourth shot of the Pfizer or Moderna vaccines for people 50 and older at least four months after their previous booster.
Curated Video
Could Next COVID Wave Mean More Vaccine Shots?
It's been at least five months since many Americans received their last vaccine shot, and studies show immunity can decline after that time.
Curated Video
Pfizer Asks FDA To Approve Vaccine For Kids Ages 5-11
The FDA is expected to take weeks to review data before it would grant emergency use authorization.
Curated Video
U.S. Gives Full Approval To Moderna's COVID-19 Vaccine
The FDA has now completed the same rigorous, time-consuming review of Moderna's shot as it has for dozens of other long-established vaccines.
Curated Video
Pfizer Says Its COVID Vaccine Is 90.7% Effective In Kids Ages 5 To 11
More than 25,000 pediatricians and primary care providers already have signed up to get the shots into little arms.
Bloomberg
FDA Clears Moderna, J&J Boosters and Backs Vaccine Mixing
The U.S. Food and Drug Administration said Moderna Inc. vaccine recipients 65 and over can receive a third shot, and Johnson & Johnson recipients 18 and older are eligible for a booster shot at least two months after receiving their...
Bloomberg
Mixing Covid-19 Vaccines Raises Antibodies, Study Finds
Mixing Covid vaccines produces as much or more antibodies as using the same shot as a booster, according to preliminary results of a widely awaited U.S. government-sponsored trial. Today, FDA advisers begin meeting to debate whether...
Curated Video
President Biden To Tap Robert Califf To Again Lead The FDA
Dr. Califf served as FDA commissioner for the last 11 months of President Barack Obama's second presidential term.
Curated Video
FDA Weighs Oversight Changes After Formula, Juul Troubles
The FDA's tobacco center, which regulates traditional cigarettes and vaping products, is facing challenges navigating policy and enforcement issues.
Bloomberg
Philip Morris Has No Plans for Cannabis, CEO Says
Sep.21 -- Andre Calantzopoulos, chief executive officer of Philip Morris International Inc., discusses the company's commitment to replace cigarettes with alternative products. He speaks with Bloomberg's Vonnie Quinn and Guy Johnson on...
Bloomberg
KKR Looks to Take Walgreens Private
Nov.11 -- KKR & Co. has formally approached drugstore giant Walgreens Boots Alliance Inc. about a deal to take the company private, in what could be the biggest-ever leveraged buyout, people familiar with the matter said. Bloomberg's...
Curated Video
FDA Approves First Ebola Treatment
Regeneron Pharmaceuticals got approval for the antibody mixture after it was tested on 382 children and adults.
Curated Video
FDA Will Consider OK'ing COVID-19 Vaccine Before End Of Phase 3 Trials
The head of the FDA says he’d consider bypassing the usual approval process to get a coronavirus vaccine out as soon as possible.
Bloomberg
Astra Seeks Vaccine Confidence Boost From U.S. Trial Data
Mar.22 -- AstraZeneca Biopharma Business Unit EVP Ruud Dobber discusses U.S. clinical trial results of the company’s Covid-19 vaccine, European concerns about blood clots, and the brewing battle of vaccine supplies in Europe. He speaks...
Curated Video
U.S. Resumes Giving Johnson And Johnson Vaccine With Warning
It was on hold for 11 days amid concerns about rare but serious blood clots.
Curated Video
Moderna Seeks OK For Emergency Approval For COVID Vaccine, Now What?
Health experts agree multiple vaccine candidates need to succeed for the world to get hold of the coronavirus pandemic.
Curated Video
Johnson & Johnson Says One-Shot COVID Vaccine Candidate Is Effective
The company says it's about 66% effective at preventing illness from COVID-19, and it only requires one shot.
Curated Video
FDA Will Review Johnson & Johnson Vaccine
Johnson & Johnson said its COVID vaccine candidate was 72% effective in a late stage trial.
Bloomberg
FDA Expected to Approve Use of Pfizer Vaccine: Johns Hopkins
Dec.04 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses he timeline for a rollout of a Covid-19 vaccine in the U.S. and adjusting coronavirus self-isolation guidelines. He speaks with...
Bloomberg
AstraZeneca Covid Vaccine 79% Effective in U.S. Clinical Trial
Mar.22 -- Johns Hopkins Center for Health Security Senior Scholar Jennifer Nuzzo discusses U.S. clinical trial data for AstraZeneca Plc’s coronavirus vaccine. She speaks on "Bloomberg Surveillance." The Bloomberg School of Public Health...